BioNeutral's Chief Scientist Featured on Discovery News

Dr. Andy Kielbania Discusses the Military Applications of Their Antimicrobial and Disinfecting Products

Andy Kielbania, Ph.D., Chief Scientist of BioNeutral Group, Inc. (OTCBB: BONU), a chemical technology-based life science company, is featured in a video titled “Tech: Killing Anthrax Faster and Greener” posted on Discovery News, an online news outlet operated by Discovery Communications, the corporate parent of the Discovery Channel.

Filmed at the BioNeutral laboratory in Newark, NJ, the video highlights the company’s environmentally responsible military-grade product platform, Ygiene™. Dr. Kielbania discusses the applications of his chemistry-based technology, which has been shown capable in independent testing of killing deadly anthrax spores in an efficient manner, allowing for the quick rehabilitation of a previously toxin-contaminated workspace.

Ygiene™ is not yet registered with the Environmental Protection Agency (EPA) or available commercially in the United States. Ygiene™ Professional Disinfectant Product and Multipurpose Cleaner and Disinfectant Product are registered and approved in Germany and are allowed in the UK, France and Sweden.

Watch The Full Video

About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a specialty chemical technology-based life science company that is developing and intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous microorganisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene™ and Ogiene™, are both eco-friendly. The Company has combined these widely used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral’s proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene™ brand have not yet been submitted to the EPA for approval for sale in the United States; however they have been approved in Germany and are allowed in the UK, France and Sweden.

Forward-Looking Statements
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.

Source: Business Wire/Yahoo Finance